Diagnosis of ECMO Cannula Infection: Prospective Comparison of Sampling Methods (ECMO-CSI-DIAG)
Diagnosis of ECMO Cannula Infection: a Prospective Comparison of Sampling Methods
Extracorporeal membrane oxygenation (ECMO) is increasingly used as rescue support in patients with refractory respiratory and/or circulatory failure. ECMO cannula site infection (ECMO-CSI) complicates approximately 10% of ECMO runs and is associated with septic shock, prolonged intensive care unit (ICU) stay and increased mortality. To date, there is neither a standardized definition nor consensus diagnostic criteria for ECMO-CSI, and the optimal microbiological sampling strategy, as well as the diagnostic accuracy of the available methods, remains undetermined.
This single-center, prospective, non-interventional study aims to compare the diagnostic accuracy of three microbiological sampling methods (superficial swab of the cannula insertion site, needle aspiration along the cannula tract, and cannula tip culture) for the diagnosis of ECMO-CSI in adult patients receiving veno-venous or veno-arterial ECMO.
A superficial swab and a needle aspirate will be obtained at each cannulation site on the day ECMO-CSI is clinically suspected and on the day of decannulation. In addition, the tip of each cannula will be cultured at decannulation. The results of these index tests will be compared with a reference diagnosis of ECMO-CSI established by an adjudication committee of expert clinicians blinded to the index test results.
A total of 500 patients will be enrolled in order to obtain at least 50 patients with adjudicated ECMO-CSI.
研究概览
地位
详细说明
BACKGROUND ECMO is a life-support technique widely used in refractory respiratory and/or circulatory failure. It is associated with infectious complications, notably cannula infections, whose incidence is estimated at about 10%. These infections are associated with an increased risk of septic shock and contribute to longer ICU stay and higher mortality. There is to date neither a standardized definition nor consensus diagnostic criteria, particularly regarding the nature and diagnostic performance of the microbiological samples to be collected. Superficial swabbing of the insertion site is simple and minimally invasive but frequently yields contaminated results or results reflecting colonizing flora. More invasive methods (needle aspiration, culture of the cannula tip at decannulation) may be more specific but are less commonly performed and have not been comparatively validated. A recent international Delphi consensus identified cannula aspiration and cannula swab as the two preferred microbiological methods. The lack of an established diagnostic algorithm leads to heterogeneous management, with potential consequences for antibiotic stewardship and patient outcomes.
DESIGN Single-center, prospective, non-interventional study conducted in the medical ICU of Pitié-Salpêtrière Hospital (AP-HP, Paris, France), which manages about 300 ECMO patients per year. All adult patients on veno-venous or veno-arterial ECMO are eligible. The patient (or trusted person, relative or legal representative) is informed and the patient is included unless an objection is expressed. Inclusion period: 24 months. Participation: duration of ICU stay (maximum 2 months). Total study duration: 26 months.
SAMPLING
- Swab (performed for the research): a sterile single-use swab is applied to the cannula insertion orifice.
- Needle aspiration (standard of care): 1 mL of sterile saline is injected along the cannula through a syringe and a plastic catheter, re-aspirated and transferred to a sterile container.
- Cannula tip (standard of care): at decannulation, the distal 5 cm of the cannula is cut with a sterile blade and placed in a sterile container.
On the day the clinician in charge suspects a cannulation site infection, a swab and a needle aspiration are performed at each cannulation site. On the day of decannulation, a swab and a needle aspiration are performed at each cannulation site and the tip of each cannula is sent for culture.
MICROBIOLOGY Samples are cultured in the microbiology laboratory using the Brun-Buisson technique: suspension in 1 mL of sterile saline and vortexing for about 1 minute, then 100 microliters are plated on fresh blood agar, chocolate agar and Sabouraud agar, incubated for 48 hours to 10 days under aerobic and anaerobic conditions and read daily. In case of positive culture, identification is performed by mass spectrometry (MALDI-TOF). Each sample is recorded as culture positive or culture negative.
REFERENCE STANDARD The reference diagnosis of ECMO cannula infection is the clinical diagnosis established by an adjudication committee of three clinician experts, ruling retrospectively and blinded to the results of the index tests, on the basis of the available clinical, biological, microbiological and outcome data.
DATA Data are collected prospectively from the electronic medical record into a REDCap electronic case report form hosted by AP-HP. At each sampling: local appearance of the insertion site (photograph), general and hemodynamic status, biological inflammatory markers, nosocomial infection during the stay, antibiotic therapy within the previous 7 days, rectal colonization with a multidrug-resistant organism, positive blood culture within the previous 48 to 72 hours, duration of ECMO support.
STATISTICS The sample size was set to obtain at least 50 cases of cannula infection; with an expected incidence of 10%, 500 patients will be included. Sensitivity, specificity and predictive values of each sampling strategy are computed against the reference diagnosis. Paired comparisons use the McNemar test. Agreement between methods is assessed with the kappa coefficient. Exploratory logistic regression analyses will identify factors associated with microbiological positivity. Analyses are performed on complete cases; a failed sampling technique is considered negative.
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Charles-Edouard LUYT
- 电话号码:+33 01 42 16 38 24
- 邮箱:charles-edouard.luyt@aphp.fr
研究联系人备份
- 姓名:Laura WAKSELMAN
- 电话号码:+33 01 42 16 19 50
- 邮箱:laura.wakselman@aphp.fr
学习地点
-
-
-
Paris、法国
- Hôpital Pitié Salpêtrière, Service de médecine intensive et réanimation
-
接触:
- Charles-Edouard LUYT, MD, PhD
- 电话号码:+33 01 42 16 38 24
- 邮箱:charles-edouard.luyt@aphp.fr
-
接触:
- Laure FLURIN, MD, PhD
- 电话号码:+33 01 84 82 79 76
- 邮箱:laure.flurin@aphp.fr
-
首席研究员:
- Charles Edouard LUYT, MD, PhD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Adult patients managed in the medical intensive care unit of Pitié-Salpêtrière Hospital (Paris, France) on veno-venous or veno-arterial ECMO during the inclusion period.
描述
Inclusion Criteria:
- Age >= 18 years
- Patient admitted to the intensive care unit with veno-venous or veno-arterial ECMO
Exclusion Criteria:
- Pregnant women
- Persons deprived of liberty
- Sample collection impossible for technical reasons
- Patients on central ECMO
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
队列和干预
团体/队列 |
|---|
|
Adult patients on ECMO
Adult patients on veno-venous or veno-arterial ECMO in the ICU. Swab and needle aspiration of each cannulation site on the day of clinical suspicion of cannula infection and on the day of decannulation; culture of each cannula tip at decannulation. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Diagnostic performance of each sampling strategy (superficial swab, needle aspiration, cannula tip culture) for the diagnosis of ECMO cannula infection
大体时间:On the day of clinical suspicion of cannula infection and on the day of decannulation, up to ICU discharge (maximum 2 months)
|
Sensitivity, specificity, positive and negative predictive values of each sampling strategy, and its agreement with the reference diagnosis of cannula infection established by the adjudication committee. |
On the day of clinical suspicion of cannula infection and on the day of decannulation, up to ICU discharge (maximum 2 months)
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Factors associated with positivity of the microbiological samples
大体时间:On the day of clinical suspicion of cannula infection and on the day of decannulation, up to ICU discharge (maximum 2 months)
|
Variables assessed at each sampling: weight (kg); height (meters), BMI (kg/m2), local appearance of the cannula insertion site on a photograph (purulence, inflammatory signs), fever (temperature (°C), systolic blood pressure (mmHg), diastolic blood pressure (mmHg), heart rate (bpm), noradrenaline (µg/kg/min), dobutamine (µg/kg/min)), biological criteria: hemoglobin (g/dL), white blood cell count (G/L), CRP (mg/L), PCT (ng/l), pH, bicarbonates (mmol/L), arterial lactate (mmol/L), nosocomial infection during the stay, antibiotic therapy within 7 days before sampling, rectal colonization with a multidrug-resistant organism, positive blood culture within 48 to 72 hours before sampling, positive culture of the ECMO cannula tip, duration of ECMO support. |
On the day of clinical suspicion of cannula infection and on the day of decannulation, up to ICU discharge (maximum 2 months)
|
|
Agreement between the sampling methods
大体时间:On the day of clinical suspicion of cannula infection and on the day of decannulation, up to ICU discharge (maximum 2 months)
|
Agreement on culture positivity and on microbiological identification between swab, needle aspiration and cannula tip culture (kappa coefficient). |
On the day of clinical suspicion of cannula infection and on the day of decannulation, up to ICU discharge (maximum 2 months)
|
合作者和调查者
调查人员
- 首席研究员:Charles Edouard LUYT, MD, PhD、Assistance Publique - Hôpitaux de Paris
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
关键字
其他研究编号
- APHP260913
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.